Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron May 24, 2023 4:06pm
192 Views
Post# 35462495

RE:RE:RE:RE:so tiresome

RE:RE:RE:RE:so tiresome

DJDawg wrote: Great Science! 2 conferences in the last few months!

and 0.235....

Due to the zero lack of confidence in the ability to raise funds in any other way than PP's.

Sadly even if there were a new business development lead doing something (anything) it would take a long time for any efforts to come to fruition.



Certainly, one of the roles of a business development/operations manger is looking for out-licensing opportunities (in addition to other partnerships) as well as opportunities for collaborative research.  We have achieved the latter with our partnership with Li Ka-shing, however, there has been a lengthy void of any significant material progress being made on that front (in stall mode) for quite some time.  Hopefully, we get a positive update on that during the AGM in June.

With regards to out-licensing opportunities/other forms of partnerships, we could likely strike a better deal once a BTD is in hand.  This company's current cash position handicaps any hiring of a qualified biotech business director/MBA who's experienced in making those important connections, but having such a person at some point would no doubt help in any contract negotiations....JMHO.

<< Previous
Bullboard Posts
Next >>